A Prospective, Randomized, Controlled, Multi-Center, Pivotal Human Clinical
Trial to Evaluate the Safety and Effectiveness of Augment™ Injectable Bone Graft Compared to
Autologous Bone Graft as a Bone Regeneration Device in Foot and Ankle Fusions
Eligibility
Inclusion Criteria:
- xxx
Exclusion Criteria:
Contact
- Trish Francis, 902-473-4136, Pager 902-458-0213 Trish.Francis@nshealth.ca
PI
Dr Mark Glazebrook
Description
A Prospective, Randomized, Controlled, Multi-Center, Pivotal Human Clinical Trial to Evaluate the Safety and Effectiveness of Augment™ Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions. (Wright/BMTI)
Enrollment Currently on Hold in Canada
Sample size=201 Closed